Methoxmetamine: Difference between revisions

Latest revision as of 01:11, 20 February 2025

Methoxmetamine (also known as MXM) is a research chemical that is a structural analog of ketamine and methoxetamine. It is classified as a dissociative hallucinogen and is relatively new to the recreational drug market.

History[edit]

Methoxmetamine was first synthesized in the 21st century as a replacement for the more well-known and widely used dissociative, methoxetamine. It was introduced to the designer drug market after the banning of methoxetamine in many countries.

Pharmacology[edit]

Methoxmetamine acts primarily as an NMDA receptor antagonist. This means it blocks the action of the NMDA receptor, a specific subtype of glutamate receptor that is associated with memory, learning, and neuronal plasticity. By blocking this receptor, methoxmetamine produces a range of effects including dissociation, hallucination, and analgesia.

Effects[edit]

The effects of methoxmetamine are similar to those of other dissociative drugs. These can include feelings of detachment from one's body, distortions in perception of time and space, and intense hallucinations. The intensity of these effects can vary widely depending on the dose taken.

Legal Status[edit]

The legal status of methoxmetamine varies by country. In some countries, it is completely legal to possess and use, while in others it is classified as a controlled substance and is illegal to possess without a prescription.

Health Risks[edit]

As with any drug, use of methoxmetamine carries potential health risks. These can include physical risks such as increased heart rate and blood pressure, as well as psychological risks such as anxiety, paranoia, and potential for addiction. Due to its relatively recent emergence, the long-term effects of methoxmetamine use are not well understood.

@@ Line 35: / Line 35: @@
 {{Psychoactive substance-stub}}
 {{Pharmacology-stub}}
+<gallery>
+File:Methoxmetamine.png|Methoxmetamine
+</gallery>